Search for: "Amgen Inc"
Results 61 - 80
of 702
Sort by Relevance
|
Sort by Date
18 May 2023, 8:20 am
The case in question is Amgen Inc. v. [read post]
17 May 2023, 9:00 pm
ShareOn Thursday, May 18, we live blogged as the court issued opinions in Amgen Inc. v. [read post]
15 May 2023, 1:47 am
On January 26, 2023, Regeneron Pharmaceuticals, Inc., who sought to invalidate Amgen Inc. [read post]
1 May 2023, 10:11 am
Teva Pharmaceuticals USA, Inc. v. [read post]
27 Apr 2023, 11:51 am
The pending Supreme Court case of Amgen Inc. v. [read post]
21 Apr 2023, 9:27 am
By Chris Holman Amgen Inc. v. [read post]
21 Apr 2023, 7:07 am
Amgen Inc., v. [read post]
20 Apr 2023, 8:46 pm
These considerations were evident in the Federal Circuit's decision in Amgen Inc. v. [read post]
31 Mar 2023, 2:48 am
Cir. 2012); Amgen, Inc. v. [read post]
29 Mar 2023, 12:09 pm
ShareDuring oral argument in Amgen Inc. v. [read post]
23 Mar 2023, 11:41 am
In Amgen Inc. v. [read post]
8 Mar 2023, 2:51 pm
” Amgen Inc. v. [read post]
7 Mar 2023, 9:16 pm
Noonan -- The Supreme Court's (re)consideration of the enablement requirement expected in its decision later this year in Amgen v. [read post]
7 Mar 2023, 8:33 pm
by Dennis Crouch The pending Supreme Court case of Amgen v. [read post]
1 Mar 2023, 4:15 am
The United States Supreme Court is set to hear opening arguments in Amgen Inc. v. [read post]
1 Mar 2023, 4:15 am
The United States Supreme Court is set to hear opening arguments in Amgen Inc. v. [read post]
1 Feb 2023, 9:05 pm
As overall M&A slowed considerably in the latter half of the year in particular, healthcare remained a bright spot, with the announcements of two transactions over $15 billion (Johnson & Johnson’s $16.6 billion acquisition of Abiomed and Amgen’s $27.8 billion acquisition of Horizon Therapeutics) and an additional six deals over $3 billion. [read post]
5 Jan 2023, 10:43 am
Supreme Court on the question presented by Amgen Inc. v. [read post]
5 Jan 2023, 10:43 am
Supreme Court on the question presented by Amgen Inc. v. [read post]
29 Dec 2022, 12:10 pm
While some courts have found a plaintiff’s motion for class certification to be deficient where the plaintiff’s expert did not conduct a consumer survey, Amgen Inc. v. [read post]
